T11	B-Entity	B-Entity	0	1	N	N	B-NP	NN	O	7	NMOD	O
T11	I-Entity	I-Entity	1	2	-	-	I-NP	HYPH	O	1	P	O
O	O	O	3	6	and	and	I-NP	CC	O	7	NMOD	O
T12	B-Entity	B-Entity	7	8	C	C	I-NP	NN	B-protein	7	NMOD	B-protein
T12	I-Entity	I-Entity	8	9	-	-	O	HYPH	I-protein	7	NMOD	I-protein
T12	I-Entity	I-Entity	9	17	terminal	terminal	B-NP	JJ	I-protein	7	NMOD	I-protein
T12	I-Entity	I-Entity	18	27	sequences	sequence	I-NP	NNS	I-protein	8	SUB	I-protein
O	O	O	28	35	control	control	B-VP	VBP	O	0	ROOT	O
O	O	O	36	47	degradation	degradation	B-NP	NN	O	8	OBJ	O
O	O	O	48	50	of	of	B-PP	IN	O	9	NMOD	O
T1	B-Protein	B-Protein	51	55	MAD3	MAD3	B-NP	NN	B-protein	16	NMOD	B-protein
O	O	O	55	56	/	/	I-NP	SYM	O	16	P	O
T2	B-Protein	B-Protein	56	57	I	I	I-NP	NN	B-protein	16	NMOD	B-protein
T2	I-Protein	I-Protein	58	63	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T2	I-Protein	I-Protein	64	65	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
T2	I-Protein	I-Protein	66	71	alpha	alpha	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	O	72	74	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	75	83	response	response	B-NP	NN	O	17	PMOD	O
O	O	O	84	86	to	to	B-PP	TO	O	18	NMOD	O
O	O	O	87	95	inducers	inducer	B-NP	NNS	O	19	PMOD	O
O	O	O	96	98	of	of	B-PP	IN	O	20	NMOD	O
T13	B-Entity	B-Entity	99	101	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T13	I-Entity	I-Entity	101	102	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T13	I-Entity	I-Entity	102	107	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T13	I-Entity	I-Entity	108	109	B	B	I-NP	NN	I-protein	26	NMOD	I-protein
O	O	O	110	118	activity	activity	I-NP	NN	O	21	PMOD	O
O	O	O	118	119	.	.	O	.	O	8	P	O

O	O	O	121	124	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	125	136	proteolytic	proteolytic	I-NP	JJ	O	3	NMOD	O
O	O	O	137	148	degradation	degradation	I-NP	NN	O	19	SUB	O
O	O	O	149	151	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	152	155	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	156	166	inhibitory	inhibitory	I-NP	JJ	B-protein	8	NMOD	B-protein
O	O	O	167	174	protein	protein	I-NP	NN	I-protein	8	NMOD	I-protein
T3	B-Protein	B-Protein	175	179	MAD3	MAD3	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	179	180	/	/	B-NP	SYM	O	13	P	O
T4	B-Protein	B-Protein	180	181	I	I	I-NP	NN	B-protein	13	NMOD	B-protein
T4	I-Protein	I-Protein	182	187	kappa	kappa	I-NP	NN	I-protein	13	NMOD	I-protein
T4	I-Protein	I-Protein	188	189	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
T4	I-Protein	I-Protein	190	195	alpha	alpha	I-NP	NN	I-protein	4	PMOD	I-protein
O	O	O	196	198	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	199	207	response	response	B-NP	NN	O	14	PMOD	O
O	O	O	208	210	to	to	B-PP	TO	O	15	NMOD	O
O	O	O	211	224	extracellular	extracellular	B-NP	JJ	O	18	NMOD	O
O	O	O	225	236	stimulation	stimulation	I-NP	NN	O	16	PMOD	O
O	O	O	237	239	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	240	241	a	a	B-NP	DT	O	22	NMOD	O
O	O	O	242	254	prerequisite	prerequisite	I-NP	JJ	O	22	NMOD	O
O	O	O	255	259	step	step	I-NP	NN	O	19	PRD	O
O	O	O	260	262	in	in	B-PP	IN	O	22	NMOD	O
O	O	O	263	266	the	the	B-NP	DT	O	25	NMOD	O
O	O	O	267	277	activation	activation	I-NP	NN	O	23	PMOD	O
O	O	O	278	280	of	of	B-PP	IN	O	25	NMOD	O
O	O	O	281	284	the	the	B-NP	DT	O	29	NMOD	O
T14	B-Entity	B-Entity	285	298	transcription	transcription	I-NP	NN	B-protein	29	NMOD	B-protein
T14	I-Entity	I-Entity	299	305	factor	factor	I-NP	NN	I-protein	33	NMOD	I-protein
T15	I-Entity	I-Entity	306	308	NF	NF	I-NP	NN	B-protein	33	NMOD	B-protein
T15	I-Entity	I-Entity	308	309	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T15	I-Entity	I-Entity	309	314	kappa	kappa	I-NP	NN	I-protein	33	NMOD	I-protein
T15	I-Entity	I-Entity	315	316	B	B	I-NP	NN	I-protein	26	PMOD	I-protein
O	O	O	316	317	.	.	O	.	O	19	P	O

O	O	O	318	326	Analysis	Analysis	B-NP	NN	O	21	SUB	O
O	O	O	327	329	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	330	333	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	334	344	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	O	345	347	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	348	353	human	human	B-NP	JJ	B-protein	11	NMOD	B-protein
T5	B-Protein	B-Protein	354	355	I	I	I-NP	NN	I-protein	11	NMOD	I-protein
T5	I-Protein	I-Protein	356	361	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T5	I-Protein	I-Protein	362	363	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
T5	I-Protein	I-Protein	364	369	alpha	alpha	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	O	370	377	protein	protein	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	378	380	in	in	B-PP	IN	O	4	NMOD	O
O	O	O	381	387	stable	stable	B-NP	JJ	O	14	NMOD	O
O	O	O	388	401	transfectants	transfectant	I-NP	NNS	O	12	PMOD	O
O	O	O	402	404	of	of	B-PP	IN	O	14	NMOD	O
O	O	O	405	410	mouse	mouse	B-NP	NN	B-cell_line	20	NMOD	B-cell_line
O	O	O	411	414	70Z	70Z	I-NP	NN	I-cell_line	20	NMOD	I-cell_line
O	O	O	414	415	/	/	B-NP	SYM	I-cell_line	20	NMOD	I-cell_line
O	O	O	415	416	3	3	B-NP	CD	I-cell_line	20	NMOD	I-cell_line
O	O	O	417	422	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	O	423	428	shows	show	B-VP	VBZ	O	0	ROOT	O
O	O	O	429	433	that	that	B-SBAR	IN	O	21	VMOD	O
O	O	O	433	434	,	,	O	,	O	22	P	O
O	O	O	435	437	as	as	B-PP	IN	O	22	DEP	O
O	O	O	438	441	for	for	B-PP	IN	O	24	PMOD	O
O	O	O	442	445	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	446	456	endogenous	endogenous	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	O	457	463	murine	murine	I-NP	JJ	I-protein	29	NMOD	I-protein
O	O	O	464	471	protein	protein	I-NP	NN	I-protein	25	PMOD	I-protein
O	O	O	471	472	,	,	O	,	O	22	P	O
O	O	O	473	482	exogenous	exogenous	B-NP	JJ	O	36	SUB	O
T6	B-Protein	B-Protein	483	484	I	I	I-NP	NN	B-protein	35	NMOD	B-protein
T6	I-Protein	I-Protein	485	490	kappa	kappa	I-NP	NN	I-protein	35	NMOD	I-protein
T6	I-Protein	I-Protein	491	492	B	B	I-NP	NN	I-protein	35	NMOD	I-protein
T6	I-Protein	I-Protein	493	498	alpha	alpha	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	O	499	501	is	be	B-VP	VBZ	O	22	SBAR	O
O	O	O	502	510	degraded	degrade	I-VP	VBN	O	36	VC	O
O	O	O	511	513	in	in	B-PP	IN	O	37	VMOD	O
O	O	O	514	522	response	response	B-NP	NN	O	38	PMOD	O
O	O	O	523	525	to	to	B-PP	TO	O	39	NMOD	O
O	O	O	526	534	inducers	inducer	B-NP	NNS	O	40	PMOD	O
O	O	O	535	537	of	of	B-PP	IN	O	41	NMOD	O
T16	B-Entity	B-Entity	538	540	NF	NF	B-NP	NN	B-protein	47	NMOD	B-protein
T16	I-Entity	I-Entity	540	541	-	-	B-NP	HYPH	I-protein	47	NMOD	I-protein
T16	I-Entity	I-Entity	541	546	kappa	kappa	I-NP	NN	I-protein	47	NMOD	I-protein
T16	I-Entity	I-Entity	547	548	B	B	I-NP	NN	I-protein	47	NMOD	I-protein
O	O	O	549	557	activity	activity	I-NP	NN	O	42	PMOD	O
O	O	O	557	558	,	,	O	,	O	41	P	O
O	O	O	559	563	such	such	B-PP	JJ	O	50	PMOD	O
O	O	O	564	566	as	as	I-PP	IN	O	41	NMOD	O
O	O	O	567	574	phorbol	phorbol	B-NP	NN	O	53	NMOD	O
O	O	O	575	584	myristate	myristate	I-NP	NN	O	53	NMOD	O
O	O	O	585	592	acetate	acetate	I-NP	NN	O	55	NMOD	O
O	O	O	593	595	or	or	I-NP	CC	O	55	NMOD	O
O	O	O	596	614	lipopolysaccharide	lipopolysaccharide	I-NP	NN	O	50	PMOD	O
O	O	O	614	615	.	.	O	.	O	21	P	O

O	O	O	616	618	In	In	B-PP	IN	O	21	VMOD	O
O	O	O	619	627	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	627	628	,	,	O	,	O	21	P	O
O	O	O	629	641	pretreatment	pretreatment	B-NP	NN	O	21	SUB	O
O	O	O	642	644	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	645	648	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	649	654	cells	cell	I-NP	NNS	O	5	PMOD	O
O	O	O	655	659	with	with	B-PP	IN	O	4	NMOD	O
O	O	O	660	663	the	the	B-NP	DT	O	18	NMOD	O
T17	B-Entity	B-Entity	664	674	proteasome	proteasome	I-NP	NN	B-protein	11	NMOD	B-protein
O	O	O	675	684	inhibitor	inhibitor	I-NP	NN	O	18	NMOD	O
O	O	O	685	686	N	N	I-NP	NN	O	18	NMOD	O
O	O	O	686	687	-	-	B-NP	HYPH	O	18	P	O
O	O	O	687	689	Ac	Ac	I-NP	NN	O	18	NMOD	O
O	O	O	689	690	-	-	B-NP	HYPH	O	18	P	O
O	O	O	690	693	Leu	Leu	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	693	694	-	-	B-NP	HYPH	O	18	P	O
O	O	O	694	697	Leu	Leu	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	697	698	-	-	B-NP	HYPH	O	18	P	O
O	O	O	698	709	norleucinal	norleucinal	B-ADJP	JJ	O	8	PMOD	O
O	O	O	710	718	inhibits	inhibit	B-VP	VBZ	O	0	ROOT	O
O	O	O	719	723	this	this	B-NP	DT	O	26	NMOD	O
O	O	O	724	730	ligand	ligand	I-NP	NN	O	26	NMOD	O
O	O	O	730	731	-	-	B-VP	HYPH	O	26	NMOD	O
O	O	O	731	738	induced	induce	B-NP	VBN	O	26	NMOD	O
O	O	O	739	750	degradation	degradation	I-NP	NN	O	21	OBJ	O
O	O	O	751	754	and	and	O	CC	O	21	VMOD	O
O	O	O	754	755	,	,	O	,	O	21	P	O
O	O	O	756	758	in	in	B-PP	IN	O	21	VMOD	O
O	O	O	759	768	agreement	agreement	B-NP	NN	O	29	PMOD	O
O	O	O	769	773	with	with	B-PP	IN	O	29	PMOD	O
O	O	O	774	782	previous	previous	B-NP	JJ	O	33	NMOD	O
O	O	O	783	790	studies	study	I-NP	NNS	O	29	PMOD	O
O	O	O	790	791	,	,	O	,	O	21	P	O
O	O	O	792	802	stabilizes	stabilize	B-VP	VBZ	O	21	VMOD	O
O	O	O	803	804	a	a	B-NP	DT	O	38	NMOD	O
O	O	O	805	824	hyperphosphorylated	hyperphosphorylate	I-NP	VBN	O	38	NMOD	O
O	O	O	825	829	form	form	I-NP	NN	O	35	OBJ	O
O	O	O	830	832	of	of	B-PP	IN	O	38	NMOD	O
O	O	O	833	836	the	the	B-NP	DT	O	46	NMOD	O
O	O	O	837	842	human	human	I-NP	JJ	B-protein	46	NMOD	B-protein
T7	B-Protein	B-Protein	843	844	I	I	I-NP	NN	I-protein	46	NMOD	I-protein
T7	I-Protein	I-Protein	845	850	kappa	kappa	I-NP	NN	I-protein	46	NMOD	I-protein
T7	I-Protein	I-Protein	851	852	B	B	I-NP	NN	I-protein	46	NMOD	I-protein
T7	I-Protein	I-Protein	853	858	alpha	alpha	I-NP	NN	I-protein	46	NMOD	I-protein
O	O	O	859	866	protein	protein	I-NP	NN	I-protein	39	PMOD	I-protein
O	O	O	866	867	.	.	O	.	O	21	P	O

O	O	O	868	870	By	By	B-PP	IN	O	15	VMOD	O
O	O	O	871	881	expressing	express	B-VP	VBG	O	1	PMOD	O
O	O	O	882	888	mutant	mutant	B-NP	JJ	O	4	NMOD	O
O	O	O	889	894	forms	form	I-NP	NNS	O	2	OBJ	O
O	O	O	895	897	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	898	901	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	902	907	human	human	I-NP	JJ	B-protein	8	NMOD	B-protein
O	O	O	908	915	protein	protein	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	916	918	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	919	923	this	this	B-NP	DT	O	12	NMOD	O
O	O	O	924	928	cell	cell	I-NP	NN	O	12	NMOD	O
O	O	O	929	933	line	line	I-NP	NN	O	9	PMOD	O
O	O	O	933	934	,	,	O	,	O	15	P	O
O	O	O	935	937	we	we	B-NP	PRP	O	15	SUB	O
O	O	O	938	942	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	943	947	been	be	I-VP	VBN	O	15	VC	O
O	O	O	948	952	able	able	B-ADJP	JJ	O	16	PRD	O
O	O	O	953	955	to	to	B-VP	TO	O	19	VMOD	O
O	O	O	956	965	delineate	delineate	I-VP	VB	O	17	AMOD	O
O	O	O	966	969	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	970	979	sequences	sequence	I-NP	NNS	O	19	OBJ	O
O	O	O	980	991	responsible	responsible	B-ADJP	JJ	O	21	NMOD	O
O	O	O	992	995	for	for	B-PP	IN	O	22	AMOD	O
O	O	O	996	1000	both	both	O	CC	O	32	NMOD	O
O	O	O	1001	1004	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1005	1011	ligand	ligand	I-NP	NN	O	32	NMOD	O
O	O	O	1011	1012	-	-	B-VP	HYPH	O	32	P	O
O	O	O	1012	1019	induced	induce	B-NP	VBN	O	29	NMOD	O
O	O	O	1020	1035	phosphorylation	phosphorylation	I-NP	NN	O	32	NMOD	O
O	O	O	1036	1039	and	and	O	CC	O	32	NMOD	O
O	O	O	1040	1043	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	1044	1055	degradation	degradation	I-NP	NN	O	23	PMOD	O
O	O	O	1056	1058	of	of	B-PP	IN	O	32	NMOD	O
T8	B-Protein	B-Protein	1059	1060	I	I	B-NP	NN	B-protein	37	NMOD	B-protein
T8	I-Protein	I-Protein	1061	1066	kappa	kappa	I-NP	NN	I-protein	37	NMOD	I-protein
T8	I-Protein	I-Protein	1067	1068	B	B	I-NP	NN	I-protein	37	NMOD	I-protein
T8	I-Protein	I-Protein	1069	1074	alpha	alpha	I-NP	NN	I-protein	33	PMOD	I-protein
O	O	O	1074	1075	.	.	O	.	O	15	P	O

O	O	O	1076	1079	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	O	1080	1087	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1088	1092	show	show	B-VP	VBP	O	0	ROOT	O
O	O	O	1093	1097	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1098	1106	deletion	deletion	B-NP	NN	O	22	SUB	O
O	O	O	1107	1109	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	1110	1113	the	the	B-NP	DT	O	9	NMOD	O
T18	B-Entity	B-Entity	1114	1115	C	C	I-NP	NN	B-protein	9	NMOD	B-protein
T18	I-Entity	I-Entity	1116	1124	terminus	terminus	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	1125	1127	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1128	1131	the	the	B-NP	DT	O	16	NMOD	O
T9	B-Protein	B-Protein	1132	1133	I	I	I-NP	NN	B-protein	16	NMOD	B-protein
T9	I-Protein	I-Protein	1134	1139	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T9	I-Protein	I-Protein	1140	1141	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
T9	I-Protein	I-Protein	1142	1147	alpha	alpha	I-NP	NN	I-protein	16	NMOD	I-protein
T19	B-Entity	B-Entity	1148	1156	molecule	molecule	I-NP	NN	I-protein	10	PMOD	I-protein
T19	I-Entity	I-Entity	1157	1159	up	up	B-PP	IN	O	18	PMOD	O
T19	I-Entity	I-Entity	1160	1162	to	to	B-PP	TO	O	5	NMOD	O
T19	I-Entity	I-Entity	1163	1168	amino	amino	B-NP	JJ	B-protein	20	NMOD	B-protein
T19	I-Entity	I-Entity	1169	1173	acid	acid	I-NP	NN	I-protein	18	PMOD	I-protein
T19	I-Entity	I-Entity	1174	1177	279	279	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	O	1178	1187	abolishes	abolish	B-VP	VBZ	O	4	SBAR	O
O	O	O	1188	1200	constitutive	constitutive	B-ADJP	JJ	O	29	NMOD	O
O	O	O	1201	1204	but	but	O	CC	O	29	NMOD	O
O	O	O	1205	1208	not	not	O	RB	O	24	DEP	O
O	O	O	1209	1215	ligand	ligand	B-NP	NN	O	29	NMOD	O
O	O	O	1215	1216	-	-	B-NP	HYPH	O	29	NMOD	O
O	O	O	1216	1225	inducible	inducible	I-NP	JJ	O	29	NMOD	O
O	O	O	1226	1241	phosphorylation	phosphorylation	I-NP	NN	O	22	OBJ	O
O	O	O	1242	1245	and	and	O	CC	O	22	VMOD	O
O	O	O	1246	1254	inhibits	inhibit	B-VP	VBZ	O	22	VMOD	O
O	O	O	1255	1261	ligand	ligand	B-NP	NN	O	35	NMOD	O
O	O	O	1261	1262	-	-	B-NP	HYPH	O	35	NMOD	O
O	O	O	1262	1271	inducible	inducible	I-NP	JJ	O	35	NMOD	O
O	O	O	1272	1283	degradation	degradation	I-NP	NN	O	31	OBJ	O
O	O	O	1283	1284	.	.	O	.	O	3	P	O

O	O	O	1285	1292	Further	Further	B-NP	JJ	O	2	NMOD	O
O	O	O	1293	1301	analysis	analysis	I-NP	NN	O	3	SUB	O
O	O	O	1302	1309	reveals	reveal	B-VP	VBZ	O	0	ROOT	O
O	O	O	1310	1314	that	that	B-SBAR	IN	O	31	DEP	O
O	O	O	1315	1318	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1319	1328	inducible	inducible	I-NP	JJ	O	7	NMOD	O
O	O	O	1329	1344	phosphorylation	phosphorylation	I-NP	NN	O	13	SUB	O
O	O	O	1345	1347	of	of	B-PP	IN	O	7	NMOD	O
T10	B-Protein	B-Protein	1348	1349	I	I	B-NP	NN	B-protein	12	NMOD	B-protein
T10	I-Protein	I-Protein	1350	1355	kappa	kappa	I-NP	NN	I-protein	12	NMOD	I-protein
T10	I-Protein	I-Protein	1356	1357	B	B	I-NP	NN	I-protein	12	NMOD	I-protein
T10	I-Protein	I-Protein	1358	1363	alpha	alpha	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	1364	1368	maps	map	B-VP	VBZ	O	4	SBAR	O
O	O	O	1369	1371	to	to	B-PP	TO	O	13	VMOD	O
O	O	O	1372	1375	two	two	B-NP	CD	O	16	NMOD	O
T20	B-Entity	B-Entity	1376	1383	serines	serine	I-NP	NNS	O	14	PMOD	O
O	O	O	1384	1386	in	in	B-PP	IN	O	16	NMOD	O
O	O	O	1387	1390	the	the	B-NP	DT	O	20	NMOD	O
T21	B-Entity	B-Entity	1391	1392	N	N	I-NP	NN	B-protein	20	NMOD	B-protein
T21	I-Entity	I-Entity	1393	1401	terminus	terminus	I-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	1402	1404	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	1405	1408	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	1409	1416	protein	protein	I-NP	NN	O	21	PMOD	O
O	O	O	1417	1418	(	(	O	(	O	29	DEP	O
T22	B-Entity	B-Entity	1418	1426	residues	residue	B-NP	NNS	O	29	DEP	O
T23	I-Entity	I-Entity	1427	1429	32	32	B-NP	CD	O	28	NMOD	O
O	O	O	1430	1433	and	and	I-NP	CC	O	28	NMOD	O
T24	B-Entity	B-Entity	1434	1436	36	36	I-NP	CD	O	25	NMOD	O
O	O	O	1436	1437	)	)	O	)	O	16	NMOD	O
O	O	O	1438	1441	and	and	O	CC	O	31	DEP	O
O	O	O	1442	1446	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1447	1450	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	1451	1459	mutation	mutation	I-NP	NN	O	37	SUB	O
O	O	O	1460	1462	of	of	B-PP	IN	O	33	NMOD	O
O	O	O	1463	1469	either	either	B-NP	DT	O	36	NMOD	O
O	O	O	1470	1477	residue	residue	I-NP	NN	O	34	PMOD	O
O	O	O	1478	1480	is	be	B-VP	VBZ	O	31	SBAR	O
O	O	O	1481	1491	sufficient	sufficient	B-ADJP	JJ	O	37	PRD	O
O	O	O	1492	1494	to	to	B-VP	TO	O	40	VMOD	O
O	O	O	1495	1502	abolish	abolish	I-VP	VB	O	38	AMOD	O
O	O	O	1503	1509	ligand	ligand	B-NP	NN	O	44	NMOD	O
O	O	O	1509	1510	-	-	B-NP	HYPH	O	44	NMOD	O
O	O	O	1510	1517	induced	induce	I-NP	VBN	O	44	NMOD	O
O	O	O	1518	1529	degradation	degradation	I-NP	NN	O	40	OBJ	O
O	O	O	1529	1530	,	,	O	,	O	3	P	O
O	O	O	1531	1538	whereas	whereas	O	IN	O	3	VMOD	O
O	O	O	1539	1543	both	both	B-NP	DT	O	48	NMOD	O
T25	B-Entity	B-Entity	1544	1552	residues	residue	I-NP	NNS	O	46	SBAR	O
O	O	O	1553	1557	must	must	B-VP	MD	O	48	NMOD	O
O	O	O	1558	1560	be	be	I-VP	VB	O	49	VC	O
O	O	O	1561	1568	mutated	mutate	I-VP	VBN	O	50	VC	O
O	O	O	1569	1571	to	to	B-VP	TO	O	53	VMOD	O
O	O	O	1572	1579	abolish	abolish	I-VP	VB	O	49	VMOD	O
O	O	O	1580	1589	inducible	inducible	B-NP	JJ	O	55	NMOD	O
O	O	O	1590	1605	phosphorylation	phosphorylation	I-NP	NN	O	53	OBJ	O
O	O	O	1606	1608	of	of	B-PP	IN	O	55	NMOD	O
O	O	O	1609	1612	the	the	B-NP	DT	O	58	NMOD	O
O	O	O	1613	1620	protein	protein	I-NP	NN	O	56	PMOD	O
O	O	O	1620	1621	.	.	O	.	O	3	P	O

O	O	O	1622	1623	(	(	O	(	O	7	DEP	O
O	O	O	1623	1631	ABSTRACT	ABSTRACT	B-NP	NN	O	7	DEP	O
O	O	O	1632	1641	TRUNCATED	TRUNCATED	B-VP	VBN	O	2	NMOD	O
O	O	O	1642	1644	AT	AT	B-PP	IN	O	3	VMOD	O
O	O	O	1645	1648	250	250	B-NP	CD	O	6	NMOD	O
O	O	O	1649	1654	WORDS	WORDS	I-NP	NNS	O	4	PMOD	O
O	O	O	1654	1655	)	)	O	)	O	0	ROOT	O
